Aprea Therapeutics, Inc. (APRE)

Form 4 sales, Form 144 notices and lockup dates

Sales chart range
Log in to watch APRE
Latest sale
$30k
Oct 18 · No plan
Form 4 sales
19
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
4
Plan not stated
1
No plan
14
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleUnusual
    Sep 20, 2021 2021

    Sold 25,000 shares at $4.97 ($124k)

    Abrahmsen Lars B., SVP, Chief Scientific Officer

    Sold 56.8% of holdings ($219k position)19,000 shares leftFirst sale on recordFiling

  2. 2 Form 4 saleUnusual
    Sep 20, 2021 same day

    Sold 32,960 shares at $4.97 ($164k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 65.8% of holdings ($249k position)17,167 shares leftFirst sale on recordFiling

  3. 3 Form 4 saleUnusual
    Oct 1, 2021 +11 days

    Sold 27,500 shares at $4.89 ($134k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 61.6% of holdings ($218k position)17,167 shares leftFiling

  4. 4 Form 4 saleUnusual
    Oct 1, 2021 same day

    Sold 50,000 shares at $4.89 ($244k)

    Abrahmsen Lars B., SVP, Chief Scientific Officer

    Sold 72.5% of holdings ($337k position)19,000 shares leftFiling

  5. 5 Form 4 saleUnusual
    Nov 1, 2021 +31 days

    Sold 27,500 shares at $5.00 ($138k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 61.6% of holdings ($223k position)17,167 shares leftFiling

  6. 6 Form 4 saleUnusual
    Dec 1, 2021 +30 days

    Sold 27,500 shares at $3.96 ($109k)

    Korbel Gregory Alan, SVP, Chief Business Officer

    Sold 61.6% of holdings ($177k position)17,167 shares left1x usual sizeFiling

  7. 7 Form 4 saleUnusual
    Feb 28, 2022 +89 days

    Sold 36,000 shares at $1.73 ($62k)

    Attar Eyal C., SVP, Chief Medical Officer

    Sold 43.4% of holdings ($144k position)47,000 shares leftFiling

  8. 8 Form 4 saleNo plan
    Oct 18, 2024 +963 days

    Sold 6,462 shares at $4.58 ($30k)

    Duey Marc, Director

    No 10b5-1 planSold 2.7% of holdings ($1.1M position)233,651 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (19)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for APRE
Source
Oct 18, 2024Oct 25, 2024Duey MarcAPREDirectorForm 4 sale6,462$30k2.7%No planSEC
Feb 28, 2022Mar 1, 2022Attar Eyal C.APRESVP, Chief Medical OfficerForm 4 sale36,000$62k43.4%UnusualSEC
Dec 1, 2021Dec 3, 2021Korbel Gregory AlanAPRESVP, Chief Business OfficerForm 4 sale27,500$109k61.6%UnusualSEC
Nov 1, 2021Nov 3, 2021Korbel Gregory AlanAPRESVP, Chief Business OfficerForm 4 sale27,500$138k61.6%UnusualSEC
Oct 1, 2021Oct 5, 2021Abrahmsen Lars B.APRESVP, Chief Scientific OfficerForm 4 sale50,000$244k72.5%UnusualSEC
Oct 1, 2021Oct 5, 2021Korbel Gregory AlanAPRESVP, Chief Business OfficerForm 4 sale27,500$134k61.6%UnusualSEC
Sep 20, 2021Sep 22, 2021Korbel Gregory AlanAPRESVP, Chief Business OfficerForm 4 sale32,960$164k65.8%UnusualSEC
Sep 20, 2021Sep 22, 2021Abrahmsen Lars B.APRESVP, Chief Scientific OfficerForm 4 sale25,000$124k56.8%UnusualSEC
Sep 16, 2021Sep 20, 2021Attar Eyal C.APRESVP, Chief Medical OfficerForm 4 sale15,968$75k16.1%Plan not statedSEC
Dec 28, 2020Feb 16, 2021Redmile Group, LLCAPRE10% ownerForm 4 sale500,000$2.8M22.0%Plan not statedSEC
Oct 5, 2020Oct 7, 20205AM Opportunities I (GP), LLCAPREOtherForm 4 sale175,000$4.4M55.8%UnusualSEC
Jul 7, 2020Jul 7, 2020KCIF Co-Investment Fund KBAPRE10% ownerForm 4 sale241,703$8.4M10.8%Plan not statedSEC
Jun 16, 2020Jun 18, 2020Rocklage Scott MAPREDirector, 10% ownerForm 4 sale120,164$4M61.3%UnusualSEC
Jun 16, 2020Jun 18, 20205AM Opportunities I (GP), LLCAPRE10% ownerForm 4 sale140,000$4.7M30.9%UnusualSEC
Jun 11, 2020Jun 15, 2020Rocklage Scott MAPREDirector, 10% ownerForm 4 sale245,000$7M75.2%UnusualSEC
Jun 11, 2020Jun 15, 20205AM Partners IV, LLCAPRE10% ownerForm 4 sale245,000$7M75.2%UnusualSEC
May 19, 2020May 21, 2020Rocklage Scott MAPREDirectorForm 4 sale255,000$9M73.8%UnusualSEC
May 19, 2020May 21, 20205AM Partners IV, LLCAPRE10% ownerForm 4 sale255,000$9M73.8%UnusualSEC
Apr 13, 2020Apr 15, 2020KDev Investments ABAPRE10% ownerForm 4 sale210,548$6.6M8.6%Plan not statedSEC